0001104659-19-008172.txt : 20190214 0001104659-19-008172.hdr.sgml : 20190214 20190214060954 ACCESSION NUMBER: 0001104659-19-008172 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181231 FILED AS OF DATE: 20190214 DATE AS OF CHANGE: 20190214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Senrigan Capital Management Ltd CENTRAL INDEX KEY: 0001539490 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 000-54192 FILM NUMBER: 19600402 BUSINESS ADDRESS: STREET 1: PO BOX 309, UGLAND HOUSE CITY: GEORGE TOWN STATE: E9 ZIP: 00000 BUSINESS PHONE: 85231963000 MAIL ADDRESS: STREET 1: PO BOX 309, UGLAND HOUSE CITY: GEORGE TOWN STATE: E9 ZIP: 00000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Senrigan Capital Group Ltd CENTRAL INDEX KEY: 0001539491 STATE OF INCORPORATION: K3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 000-54192 FILM NUMBER: 19600403 BUSINESS ADDRESS: STREET 1: 1504 15TH FLOOR WHEELOCK HOUSE STREET 2: 20 PEDDER STREET, CENTRAL CITY: HONG KONG STATE: K3 ZIP: 00000 BUSINESS PHONE: 85231963000 MAIL ADDRESS: STREET 1: 1504 15TH FLOOR WHEELOCK HOUSE STREET 2: 20 PEDDER STREET, CENTRAL CITY: HONG KONG STATE: K3 ZIP: 00000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Taylor Nicholas CENTRAL INDEX KEY: 0001627385 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 000-54192 FILM NUMBER: 19600404 MAIL ADDRESS: STREET 1: 11TH FL,LHT TOWER,31 QUEENS ROAD CENTRAL CITY: CENTRAL STATE: K3 ZIP: 1 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REVA Medical, Inc. CENTRAL INDEX KEY: 0001496268 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 330810505 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5751 COPLEY DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92111 BUSINESS PHONE: (858) 966-3000 MAIL ADDRESS: STREET 1: 5751 COPLEY DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92111 5 1 a5.xml 5 X0306 5 2018-12-31 0 0 1 0001496268 REVA Medical, Inc. RVA:AX 0001539490 Senrigan Capital Management Ltd PO BOX 309, UGLAND HOUSE GEORGE TOWN E9 00000 CAYMAN ISLANDS 0 0 1 0 0001539491 Senrigan Capital Group Ltd 1504 15TH FLOOR WHEELOCK HOUSE 20 PEDDER STREET, CENTRAL HONG KONG K3 00000 HONG KONG 0 0 1 0 0001627385 Taylor Nicholas 11TH FL,LHT TOWER,31 QUEENS ROAD CENTRAL CENTRAL K3 1 HONG KONG 0 0 1 0 Common Stock, par value $0.0001 per share 2018-06-29 4 P 0 L 220000 A 12453969 I See footnotes Common Stock, par value $0.0001 per share 2018-06-29 4 P 0 L 17600 A 12453969 I See footnotes Common Stock, par value $0.0001 per share 2018-06-29 4 P 0 L 22400 A 12453969 I See footnotes Common Stock, par value $0.0001 per share 2018-07-16 4 S 0 L 134489 D 12453969 I See footnotes Common Stock, par value $0.0001 per share 2018-07-20 4 S 0 L 125511 D 12453969 I See footnotes Senrigan Capital Management Limited, a Cayman Islands limited company ("SCM") with a business address of PO Box 309,Ugland House, Grand Cayman, KY-1104, is filing this Form 5 jointly with Senrigan Capital Group Limited, a Hong Kong limited company ("SCG"), and Nick Taylor, a citizen of the United Kingdom each of whom has a business address of 11th Floor, LHT Tower, 31 Queens Road Central, Hong Kong and may be deemed to have a pecuniary interest in securities reported by it on this Form 5 ("the Subject Securities"). Collectively, these are the "Reporting Persons." SCM advises the accounts of the Senrigan Master Fund Limited, a Cayman Islands limited company, Senrigan US Feeder Fund Limited, a Cayman Islands limited company, and Senrigan Fund Limited, a Cayman Islands limited company (together with Senrigan Master Fund Limited and Senrigan US Feeder Fund Limited, the "Senrigan Funds"). SCM, as the investment manager to the Senrigan Funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) of the Securities Exchange Act of 1934. Pursuant to an investment advisory agreement between SCM and SCG, SCG may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Nick Taylor's position as majority owner of SCM, Nick Taylor may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. On June 29, 2018, the Reporting Persons purchased on the open market 2,600,000 CHESS Depository Instruments ("CDI") in Australia, of which US Common Sock underlies at a 1:10 ratio. These purchases were made to facilitate invidual purchases, including the following: Stephen N. Osterle, Brandi Roberts, Robert Bernard Stockman, Raymond C. Larkin Jr., Regina Groves, Richard M Kimes, and Robert Bain Thomas ("Company Insiders"), not to be held for the account of the Reporting Persons. Please see the relevant Form 4 filings made by the Company Insiders for June 29, 2018. These facilitating transactions were completed on 16 July 2018 and 20 July 2018 respectively, leaving the Reporting Persons flat, with no additional common stock acquired. Consideration was paid jointly by the Reporting Persons for the 2,600,000 CDI for a total compensation of USD $ 399,054. The total consideration paid to the Reporting Persons on 16 July was USD $204,544. The total consideration paid to the Reporting Persons on 20 July was USD $ 192,548. This led to a net loss of USD $1,962 with regard to the facilitation transaction made on behalf of the Company Insiders. Senrigan Capital Management Limited By: /s/ Nick Taylor Name: Nick Taylor Title: Director 2019-02-14 Senrigan Capital Group Limited By: /s/ Chris Nash Name: Chris Nash Title: Chief Operating Officer 2019-02-14 /s/ Nick Taylor 2019-02-14